Responsible for leading the Finance Integrations for acquisitions, serving as the Finance Business Partner to the growing Global Diagnostics and Genetics businesses, and supporting the Commercial Development, Business Development and Strategy organizations.

Led the finance integration activities for acquisitions, including the $765 million acquisition of PHARMAQ in 2015 and the $80 million acquisition of Scandinavian Micro Biodevices in 2016. Responsible for tracking, analyzing and reporting restructuring program achievements vs. targets, including headcount reductions, projected savings and severance costs. Responsible for standardizing global SAP reports, working with finance leads and report developers.

Directed all finance activities for the U.S. Cattle and Equine business with annual net revenue of nearly $1 billion, which included the annual Operating Plan, quarterly forecasts and earnings analysis, monthly close activities and presentations to the leadership team, and review of business proposals for product pricing and acquisitions.

Led the preparation of annual Operating Plan and periodic forecasts for the Canada and Latin America Region, which had $815 million net revenue in 2014. Consolidated and analyzed monthly financial results compared to prior year, previous forecast, and budget. Provided commentary and presentations to Senior Management for the quarterly earnings release, budget and forecasts. Managed the accounting close for regional headquarters and prepared necessary journal entries. Monitored working capital metrics related to accounts receivable and inventory.

Responsible for providing accounting guidance to the market Controllers and Finance Directors. Supported market finance teams with maintaining adequate controls and complying with Sarbanes-Oxley requirements. Analyzed quarterly financial statement fluctuations and adequacy of reserves. Prepared Topside journal entries for the month-end close. Collaborated with local management and Corporate departments to meet deadlines and resolve issues. Implemented global workflow tool to efficiently obtain and document approvals for commercial activities.

Led various work streams for the carve-out financial statements related to the spin-off of Pfizer’s Animal Health business (now Zoetis Inc.) and the $11.9 billion divestiture of Pfizer’s Nutrition business. Determined and recorded carve-out adjustments for responsible areas, which required extensive analysis, collaboration with various departments, and management of external resources.

Responsible for financial planning and analysis of Animal Health headquarter cost centers and global Finance costs. Recorded month-end journal entries in the general ledger. Monitored account reconciliations to ensure they were completed and approved on a timely basis. Reviewed and approved requests for restructuring accounting treatment and capital spending.

Responsible for the preparation of financial statements and related notes in accordance with U.S. GAAP for SEC filings including the 10-K and 10-Q. Collaborated with domestic and international affiliates to obtain and review information required for financial statement disclosures and governmental reports. Reviewed and validated purchase accounting transactions related to the Wyeth acquisition. Provided technical accounting guidance to staff and affiliate management.

Directed capital markets activities including $11 billion long-term debt and $5 billion interest rate swaps. Forecasted global cash flows and interest income/expense for $17 billion cash/investments and $11 billion debt. Managed over 50 equity investments and promissory notes resulting primarily from R&D collaboration deals. Executed open market stock repurchases through Wyeth’s $5 billion share repurchase program. Reviewed and released wire transfers up to an authorized daily threshold of $250 million. Responsible for the $9 million Domestic Treasury departmental budget. Managed the relationship with Wyeth’s transfer agent. Coordinated the distribution of Annual Stockholders Meeting proxy materials to 240,000 stockholders.

Held positions of increasing responsibility in the Wyeth Internal Audit department from 2003-2007, including Audit Manager (2006-2007), Audit Supervisor (2005-2006), Senior Auditor (2004-2005) and Staff Auditor (2003-2004). Managed various projects and field reviews at Wyeth affiliates, ensuring that planning, fieldwork, and audit reports were completed timely and effectively. Presented issues and recommendations to affiliate and divisional management. Supervised teams of four to five individuals and evaluated the performance of staff members. Assessed the adequacy and effectiveness of internal controls at domestic and international affiliates. Evaluated affiliates’ compliance with Corporate policies and U.S. GAAP, and assessed the effectiveness of local policies and procedures. Reviewed and prepared work papers to adequately document the audit work performed and support conclusions made.

Leader of Wyeth’s Sarbanes-Oxley (“SOX”) program, including the development of Wyeth’s approach and methodology to ensure compliance with Section 404 of the SOX Act. Performed an annual risk assessment to determine the scope of Wyeth’s SOX testing. Created and implemented formal instructions for Wyeth affiliates/divisions to comply with SOX requirements. Trained and assisted affiliate SOX coordinators with their SOX internal control documentation, peer testing and remediation of deficiencies. Developed an integrated SOX audit plan with external auditors to leverage work performed by Internal Audit and create efficiencies. Worked with external auditors and affiliate SOX coordinators to ensure that deficiencies were remediated timely. Assessed internal control questionnaires completed by Wyeth’s domestic and international affiliates.

Positions included Senior Auditor (2003) and Staff Auditor (2000-2002). Planned, supervised and completed audit and review engagements in various industries. Prepared and reviewed financial statements and related footnote disclosures in accordance with U.S. GAAP. Assessed internal control environments, inherent risks, and fraud risk factors. Communicated accounting issues and operational recommendations to client management. Supervised and trained staff members. Clients included an SEC outdoor advertising company, an SEC alcoholic beverages producer/supplier, a pharmaceutical start-up corporation, real estate partnerships, casinos, various nonprofit organizations, charitable foundations, country clubs, and 401K plans.